Source: Frontiers in Immunology. Unidades: FM, ICB
Subjects: FISIOLOGIA, ESTRESSE OXIDATIVO, INFLAMAÇÃO, COLINÉRGICOS, ANTI-INFLAMATÓRIOS, CARDIOPATIAS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, OBESIDADE, ENZIMAS OXIRREDUTORAS, CITOCINAS, FREQUÊNCIA CARDÍACA
ABNT
MIYAHARA, Carine Teles Sangleti et al. The cholinergic drug galantamine alleviates oxidative stress alongside anti-inflammatory and cardio-metabolic effects in subjects with the metabolic syndrome in a randomized trial. Frontiers in Immunology, v. 12, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2021.613979. Acesso em: 16 nov. 2024.APA
Miyahara, C. T. S., Katayama, K. Y., Angelis, K. D., Moraes, T. L. de, Araújo, A. A., Lopes, H. F., et al. (2021). The cholinergic drug galantamine alleviates oxidative stress alongside anti-inflammatory and cardio-metabolic effects in subjects with the metabolic syndrome in a randomized trial. Frontiers in Immunology, 12, 1-12. doi:10.3389/fimmu.2021.613979NLM
Miyahara CTS, Katayama KY, Angelis KD, Moraes TL de, Araújo AA, Lopes HF, Camacho C, Bortolotto LA, Michelini LC, Irigoyen MCC, Olofsson PS, Barnaby DP, Tracey KJ, Pavlov VA, Colombo FMC. The cholinergic drug galantamine alleviates oxidative stress alongside anti-inflammatory and cardio-metabolic effects in subjects with the metabolic syndrome in a randomized trial [Internet]. Frontiers in Immunology. 2021 ; 12 1-12.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fimmu.2021.613979Vancouver
Miyahara CTS, Katayama KY, Angelis KD, Moraes TL de, Araújo AA, Lopes HF, Camacho C, Bortolotto LA, Michelini LC, Irigoyen MCC, Olofsson PS, Barnaby DP, Tracey KJ, Pavlov VA, Colombo FMC. The cholinergic drug galantamine alleviates oxidative stress alongside anti-inflammatory and cardio-metabolic effects in subjects with the metabolic syndrome in a randomized trial [Internet]. Frontiers in Immunology. 2021 ; 12 1-12.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fimmu.2021.613979